ABSTRACT -Background and Aim -Helicobacter pylori has been proven to be responsible for causing various gastrointestinal disorders including gastric adenocarcinoma. Several genes of pathogen (the genes of the cag-PAI, vacA, iceA, and babA) either in combination or independently have been reported to significantly increase the risk of ulceration/gastric carcinoma, with the cagA gene having the strongest predictive value. Pursuit to identify new genes which could serve as a marker of overt disease progression, lead to the discovery of hrgA gene. Methods -Fifty-six indigenous strains of H. pylori from subjects with various gastric disorder were screened to assess the status of hrgA gene along with the cagA gene using simple polymerase chain reaction using specific oligonucleotide primers. Post-amplification, amplicons were subjected for sequencing to identify any strain specific variations in sequences from the H. pylori isolated from different disease manifestations. Histopathological analysis was done to ascertain any significant change in the histological scores of subjects infected with cagA+/hrgA+ and cagA-/hrg+ strains. Results -All the 56 (100%) subjects amplified with the oligonucleotide primers specific to hrgA gene, whereas 81.71% subjects showed the presence of cagA gene. Sequencing of the amplimers showed 99% homology. Histology of the cagA+/hrgA+ and cagA-/ hrg+ subjects did not show any significant difference. Conclusion -hrgA gene of Helicobacter pylori is not a ideal surrogate marker for identifying individuals with higher risk of developing overt gastro-duodenal diseases such as neoplasia of the stomach.
INTRODUCTION
Adenocarcinoma of the stomach is one of the leading causes of cancer related deaths in the world (9) . Although the incidence of gastric cancer has declined much significantly in the West, it still remains a major type of neoplasm especially in the East Asian countries like Japan, China, and Korea (14) . Development of gastric cancer is believed to be a multi-factorial event and probably takes 3 to 4 decades to manifest. With the primary etiological agents being exposure to chemical carcinogens, Helicobacter pylori occupies a unique niche in the genesis of gastric cancer. In addition, epidemiological studies have indicated that infection with Helicobacter pylori is considered a major risk factor for gastric cancer (11) , and the WHO/ IARC (4) has classified this bacterium as a definite biological carcinogen in 1994. Though it is hypothesized that the development of cancer depends on a series of complex molecular interaction between the host and bacteria (4, 10, 11) , the precise patho-mechanisms linking H. pylori infection and gastric carcinogenesis still remains an unsolved enigma.
The predisposition among H. pylori infected individuals to develop various gastro-duodenal diseases viz duodenal ulcer (DU), gastric ulcer, gastric carcinoma and MALT-lymphoma mainly depends upon the bacterial and host factors and in part on the topography of the gastric inflammation (5, 6, 10) . Studies have identified several strain specific factors that potentially are markers for the differential risk associated with H. pylori colonization (2, 15) ; at present, the genes of the cag pathogenicity island (cag-PAI) and vacA, SADAKANE et al. (12) ; MAEDA et al. ; TIWARI et al. (13) have been reported to possess strongest predictive values. However, most strains isolated from Indian sub-continent and other East Asian countries possess these determinants irrespective of their clinical outcome. Thus, identification of specific bacterial factors that can serve as surrogate marker for the progression to ulceration or to gastric cancer remains desirable.
ANDO et al.
(
, in 2002, while working with restrictionmodification (R-M) systems, discovered potential marker Helicobacter pylori restriction endonuclease-replacing gene (hrgA) that in conjunction with cagA identified individuals associated with gastric cancer. The same study reported that though hrgA was more prevalent among the Western countries than in Asian, its prevalence was more among gastric cancer patients in Asians compared to those with benign disease. The data also suggested that the hrgA occurred more among cagA+ve H. pylori strains than those lacking cagA. These results prompted us to evaluate the prevalence of this virulence determinant among the strains isolated from the South Indian population and evaluate the presence of hrgA as a surrogate marker of overt gastrointestinal disorders.
Experimental procedure
We studied H. pylori strains from 56 dyspeptic patients (males: 32; females: 24; age range: 20-65 years) undergoinggastroscopy in the Department of Gastroenterology, Deccan College of Medical Sciences and Allied Hospitals, Hyderabad, India, for the evaluation of upper gastrointestinal symptoms. The Institutional Ethical Committee (IEC) of the hospital approved the study protocol. A total of four gastric biopsy specimens (two from the antrum and two from the corpus) were collected from each patient after taking informed consent from the subjects to take part in the study. One antral biopsy collected in brucella broth supplemented with 2% fetal calf serum (FCS) was used for culturing H. pylori, one corpus biopsy for histological lesions and the remaining two biopsy one each from the antrum and corpus was collected in phosphate buffered saline for the DNA analysis.
Bacterial strains and growth conditions
The collected biopsy specimens were transported to the laboratory, the specimens were best processed within 1 hour, if delayed the specimen was preserved at 4 0 C for 4-24 hours. The biopsy was inoculated onto the chocolate brucella agar medium (Difco Laboratories, Detroit, USA) supplemented with 7% sheep blood and antibiotics vancomycin (6 mg/mL), amphotericin-B (2 mg/mL) and polymixin-B (2500 units/mL). The plates were incubated in a microaerobic conditions at 37 0 C for 3-5 days with 90%-100% humidity. Then the plates were examined after 72 hours for H. pylori.
The isolated colonies of H. pylori were again sub cultured in solid media. Rapid urease method (RUT) a touch cytology method was also done by inoculating few colonies into 250 µL urea broth comprising phenol red indicator. The presence of urease activity by a rapid change in color from yellow to pink indicated active H. pylori. The culture was considered to be positive for H. pylori by observing small, translucent, tiny colonies, which on staining gave Gram-negative staining.
DNA extraction and PCR amplification
Genomic DNA isolation from 36 pure H. pylori cultures and 56 biopsy samples was done using a standard protocol described previously (8) . The isolated DNA was then amplified for the presence of target genes viz., cagA, hrgA and hpyIIIR of H. pylori using specific oligonucleotide primers and PCR conditions listed in Tables 1 and 2 . The products of amplification were subsequently electrophoresed in 1.5% agarose gel stained with ethidium bromide to visualize the presence of amplified genes. All the photographic registries were performed using a bio-rad gel documentation system.
Sequencing of hrgA gene of H. pylori
Following amplification using hrgAF and hrgAR primers, the amplimers were sequenced directly after purification with the QIAquick gel extraction kit (Qiagen) using the big dye terminator v3.1 cycle sequencing kit and injected to an ABI 3730 xl Genetic Analyzer (Applied Biosystems, Germany).
Histpathological analysis
Histopathological analysis was mainly performed to detect the presence of H. pylori and also to ascertain the presence 
Statistical analysis
The data obtained was evaluated using Student Chi (χ 2 ) square test and probability values less than 5% (P<0.05) was considered statistically significant.
RESULTS
Out of 56 patients enrolled for the study, we categorized the patients according to their disease status (prepyloric ulcer-14, DU-18, non-ulcer dyspepsia-10, and gastric adenocarcinoma-14). H. pylori positivity was found in 36 (64.28%) by culture, 44 (78.57%) by RUT, 28 (50%) by histopathology, and 51 (91.07%) by biopsy DNA amplification.
Status of hrgA, wA and hpyIIIR gene locus
Of the 56 genomic DNA isolated (36 cultures and 51 biopsy samples), hrgA gene amplification was seen in all the samples screened giving a product size of 594bp. Besides this, the cagA gene was found in all (100%) the patients with pre-pyloric ulcers and gastric adenocarcinoma but only in 11 (61%) with DU and 6 (60%) with non ulcer dyspepsia (NUD), respectively. However, among the remaining 11 subjects with DU and NUD that did not amplify for the cagA gene, hrgA amplified giving the expected product ( Figure 1 and Table 3 ). The prevalence of hrgA was then compared twice to confirm the presence of hrgA gene and absence of hpyIIIR locus. No mixed genotypes of hpyIIIR/hrgA were found in this study.
Histological assessment
Analysis of the sections from each biopsy from various patients showed chronic gastritis grade II among 10 (66.67%) subjects with DU, 8 (57.14%) with pre-pyloric ulcer, 3 (37.5%) with NUD, whereas chronic grade III gastritis with atrophic gastritis was seen in 2 (13.33%) with DU, 5 (35.71%) with pre-pyloric ulcers. H-E staining showed mild intestinal metaplasia (IM) in one (6.67%) subject with DU and one (7.14%) with pre-pyloric ulcer. Among 14 gastric carcinoma subjects, high grade dysplasia was seen in 8 (57.14%) and low grade dysplasia in 3 (21.42%) subjects, the remaining 3 (21.42%) subjects showed foci of chronic atrophic gastritis with moderate IM (Figures 3 and 4) . with the strain's cagA status, and clinical manifestations and also amplification for assessing the status of hpyIIIR gene locus PCR were performed in all the reported strains and was found to be negative except for the ATCC strain 26695. (Figure 2 ) All the 56 strains were found to lack the hpyIIIR locus and positive for hrgA gene. Samples were amplified 
Sequence analysis
Sequences obtained were compared using BLAST n with the NCBI database. Sequencing analysis showed the presence of hrgA gene of H. pylori with a homology of 99%.
DISCUSSION
The present study evaluated the presence of Helicobacter pylori restriction endonuclease-replacing gene (hrgA) among subjects with various gastric disorders. The results of this study showed the presence of hrgA gene in all the 51 (100%) H. pylori strains isolated from each subjects with different clinical presentations.
Even though number of bacterial virulence determinants such as the genes of the cag-pathogenicity island, vacA, iceA, and babA, have been extensively studied in the past (in association with) the clinical status in various geographical regions. No significant association could be established with the presence of any of these genes with respect to the clinical outcome, the main reason being the highly plastic genome of H. pylori (6, 12, 15) , therefore in a continued pursuit to identify novel bacterial markers of H. pylori, which could serve as a surrogate marker of disease progression, ANDO et al.
(1) reported the presence of hrgA to be high among patients with gastric cancer of the Asian population than those with non-cancerous or benign form of disease. However the present study could not find any such specific association of this gene with any of the disease conditions and found that the hrgA gene was present in all the subjects included in the study irrespective of their disease status. Further this study also found that the prevalence was not dependent on the presence of the cagA gene as it was evenly distributed among the patients with cagA positive and cagA negative H. pylori strains.
As evident from the results, we could not find any significant difference in the histological pattern among the subjects infected with cagA+ve/hrgA+ve H. pylori and those with cagA-ve/hrgA+ve. These findings suggest that development of overt disease such as ulceration or gastric carcinoma cannot be predicted based on the presence or absence of a one or two bacterial virulence factors. Rather development of severe form of disease is a result of complex molecular interactions between the host and the bacterial factors over a period of time that causes significant damage to the host. In addition, the site of the stomach where H. pylori colonizes also has an important bearing on the predisposition to develop prepyloric ulcer, DU and gastric cancer. Further, the environmental factors also play major role in disease manifestation besides the host and bacterial factors. This could have been one of the main reasons in ANDO et al.
(1) study that could not establish a correlation between hrgA gene and gastric cancer patients of the Western countries whereas the same was possible among the Asian gastric cancer patients.
The results obtained in the present study are in contrast to those obtained by ANDO et al.
(1) thereby suggesting that, though presence of hrgA had a higher predictive value for gastric carcinoma, our study however, could not hint at any such correlations, as hrgA gene was found to be present unequivocally in all the strains screened from various disease pathologies. The exploration for reasons responsible for these varied results warrants further investigations on large cohort population from different geographic areas. Besides this, an in depth molecular profile of the R-M systems and especially the functional role of hrgA gene would further be helpful to delineate the direct/ indirect role played by this gene in gastric carcinogenesis.
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